Facile FMR1 mRNA structure regulation by interruptions in CGG repeatsMouse models of polyglutamine diseases: review and data table. Part IThe panorama of miRNA-mediated mechanisms in mammalian cellsMouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.Small RNA Detection by in Situ Hybridization MethodsCurrent understanding of the role of microRNAs in spinocerebellar ataxiasStructural insights into CUG repeats containing the 'stretched U-U wobble': implications for myotonic dystrophyAtomic resolution structure of CAG RNA repeats: structural insights and implications for the trinucleotide repeat expansion diseasesCrystal structures of CGG RNA repeats with implications for fragile X-associated tremor ataxia syndromeCrystallographic characterization of CCG repeatsRNA structure analysis assisted by capillary electrophoresis.Sequence-non-specific effects of RNA interference triggers and microRNA regulators.Oligonucleotide-based strategies to combat polyglutamine diseases.Northern blotting analysis of microRNAs, their precursors and RNA interference triggers.The role of Dicer protein partners in the processing of microRNA precursors.Diced triplets expose neurons to RISC.An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseasesStructural features of microRNA (miRNA) precursors and their relevance to miRNA biogenesis and small interfering RNA/short hairpin RNA design.RNA structure of trinucleotide repeats associated with human neurological diseases.Triplet repeat RNA structure and its role as pathogenic agent and therapeutic targetStructural aspects of microRNA biogenesis.Repetitive sequences that shape the human transcriptome.In Vitro Expansion of CAG, CAA, and Mixed CAG/CAA RepeatsHuntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathwayPathogenesis of spinocerebellar ataxias viewed from the RNA perspective.RNA imaging in living cells - methods and applications.Nucleotide sequence of miRNA precursor contributes to cleavage site selection by Dicer.Structure analysis of microRNA precursors.RNA toxicity in polyglutamine disorders: concepts, models, and progress of researchRegulation of huntingtin gene expression by miRNA-137, -214, -148a, and their respective isomiRs.Identifying proteins that bind to specific RNAs - focus on simple repeat expansion diseases.Mutant CAG Repeats Effectively Targeted by RNA Interference in SCA7 Cells.Reduction of Huntington's Disease RNA Foci by CAG Repeat-Targeting Reagents.Structural Characteristics of Simple RNA Repeats Associated with Disease and their Deleterious Protein Interactions.Economical protocol for combined single-strand conformation polymorphism and heteroduplex analysis on a standard capillary electrophoresis apparatus.CAG repeat RNA as an auxiliary toxic agent in polyglutamine disorders.Cellular toxicity of expanded RNA repeats: focus on RNA foci.Recent advances in understanding of the immunological off-target effects of siRNA.Triplet repeats in transcripts: structural insights into RNA toxicity.Silencing of genes responsible for polyQ diseases using chemically modified single-stranded siRNAs.
P50
Q24801535-BB06AE3D-F509-4C2E-99E5-8D6FBAE33DB7Q26853025-6E5C754F-2814-4237-8BE9-77EBBE39E3D8Q27001268-784E46A3-FA10-4BB9-9B1D-06936581F3D3Q27005950-ECC87F35-1391-4EEA-BAAC-DDA1191F7828Q27011992-90C92C78-19C9-4495-A142-34A886E54DD2Q27028008-04A07E3E-B142-435E-A370-5332E8B6C58DQ27655444-15128F15-DC4B-43C6-85E3-AC0074CF0CA1Q27664034-A5FD53DD-58C0-446D-BBE0-FBB2E9BE57ABQ27667903-D39B9987-BF94-4EEE-A9B0-D05EF3034AFDQ27681279-2B27850B-4091-41A6-A640-9C8CA12AA66FQ33185171-9B46F0F2-5337-40D3-930C-AA106F08BFC7Q33566425-28D58ADF-2BFD-4525-83B4-30ECC085AAA7Q33791247-D4DDB63B-C163-4DC3-9B90-251BF7A8FF88Q33868183-93BB7AEC-B0DD-44A8-909B-06DCFA1749E5Q34097914-F65590F6-0A39-4DFA-B136-1AAD70429065Q34181404-A085BE2A-2743-4E20-989E-7FEFD00D11D4Q34187525-E9A21E51-51BD-44E4-A781-C09863CB71A3Q34338447-C488D9CF-88F0-45D3-8A01-88F5E342E94FQ34542108-C0EF6489-F7D7-417D-98E7-2EF5AAB3D6AEQ35633648-60D044B9-085A-4442-BBCB-3E645B8F90C7Q35746401-D0D789D4-6E74-418D-9440-BF539D7D57ABQ35785913-42945F3C-2774-44F0-9D44-6BE4CE4F993AQ36088618-DC5C3EF6-9CDC-4CE9-9441-C8CE9204653BQ36090810-A65AEE9B-8C73-453C-A14E-FD21D8910A29Q36128434-80CC8C12-6141-422A-A7B1-EA644C9C4211Q36189974-5042D635-CF17-418B-9B1B-18CF0073AAD2Q36370931-F0C22020-456C-4768-8F3A-403FC16B1A3BQ36587272-88B0CB6D-813B-426C-824C-27A303DBC23DQ36859984-99CD3711-C9B2-4FC7-ABBD-5A4AF3BCFE18Q37139257-013C1BEC-1DD0-4095-957B-577C3558641BQ37401085-2DC35936-B7AB-4B65-9A04-328706B32D48Q37539531-24CB8F29-B36A-4D02-B83F-1890E5010939Q37723428-A02EF676-66A3-4507-84C3-E4DD1AC06AF9Q37747172-8B9E92F9-0C8A-4589-AAC6-A4438DC6A1DBQ37781002-F0B43908-5B0F-45BD-B763-AA1089F4FD5BQ37877092-A265C9B8-37E2-43FD-A9BF-0F3AF6F1EF90Q37897768-3FF2225F-E193-4148-9C36-C78B5EBD11F2Q37948943-AB98002F-1C21-4532-8F63-857EC7FECBBDQ38050942-257FEB2F-0ACB-454D-801D-2A9338739A26Q38738886-3569F209-8DA6-4C2A-BDEB-94B74283EDC7
P50
description
Polish molecular biologist
@en
Pools bioloog
@nl
biolog polonez
@ro
biologiste polonais
@fr
biologo polacco
@it
biologo poloniarra
@eu
bitheolaí móilíneach Polannach
@ga
biólogo polaco
@es
biólogo polaco
@gl
biólogo polaco
@pt
name
Włodzimierz Krzyżosiak
@ast
Włodzimierz Krzyżosiak
@ca
Włodzimierz Krzyżosiak
@de
Włodzimierz Krzyżosiak
@en
Włodzimierz Krzyżosiak
@es
Włodzimierz Krzyżosiak
@fr
Włodzimierz Krzyżosiak
@ga
Włodzimierz Krzyżosiak
@gl
Włodzimierz Krzyżosiak
@it
Włodzimierz Krzyżosiak
@nl
type
label
Włodzimierz Krzyżosiak
@ast
Włodzimierz Krzyżosiak
@ca
Włodzimierz Krzyżosiak
@de
Włodzimierz Krzyżosiak
@en
Włodzimierz Krzyżosiak
@es
Włodzimierz Krzyżosiak
@fr
Włodzimierz Krzyżosiak
@ga
Włodzimierz Krzyżosiak
@gl
Włodzimierz Krzyżosiak
@it
Włodzimierz Krzyżosiak
@nl
altLabel
Wlodzimierz J Krzyzosiak
@en
Wlodzimierz Krzyzosiak
@en
prefLabel
Włodzimierz Krzyżosiak
@ast
Włodzimierz Krzyżosiak
@ca
Włodzimierz Krzyżosiak
@de
Włodzimierz Krzyżosiak
@en
Włodzimierz Krzyżosiak
@es
Włodzimierz Krzyżosiak
@fr
Włodzimierz Krzyżosiak
@ga
Włodzimierz Krzyżosiak
@gl
Włodzimierz Krzyżosiak
@it
Włodzimierz Krzyżosiak
@nl
P214
P108
P1412
P1559
Włodzimierz Krzyżosiak
@pl
P19
P20
P21
P213
0000 0000 7170 5850
P214
P27
P31
P3124
P569
1949-01-28T00:00:00Z
P570
2017-12-21T00:00:00Z
P734
P735
P7859
viaf-101975920